These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 9951940)

  • 1. E-cadherin expression as a differentiation marker in gastric cancer.
    Karayiannakis AJ; Syrigos KN; Chatzigianni E; Papanikolaou S; Karatzas G
    Hepatogastroenterology; 1998; 45(24):2437-42. PubMed ID: 9951940
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression of the E-cadherin/catenin (alpha-, beta-, and gamma-) complex correlates with the macroscopic appearance of early gastric cancer.
    Ohene-Abuakwa Y; Noda M; Perenyi M; Kobayashi N; Kashima K; Hattori T; Pignatelli M
    J Pathol; 2000 Dec; 192(4):433-9. PubMed ID: 11113859
    [TBL] [Abstract][Full Text] [Related]  

  • 3. E-cadherin expression correlates with tumor differentiation in colorectal cancer.
    Karatzas G; Karayiannakis AJ; Syrigos KN; Chatzigianni E; Papanikolaou S; Riza F; Papanikolaou D
    Hepatogastroenterology; 1999; 46(25):232-5. PubMed ID: 10228798
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Loss of the tight junction protein claudin 4 correlates with histological growth-pattern and differentiation in advanced gastric adenocarcinoma.
    Lee SK; Moon J; Park SW; Song SY; Chung JB; Kang JK
    Oncol Rep; 2005 Feb; 13(2):193-9. PubMed ID: 15643498
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression of E-cadherin, beta-catenin, CD44s and CD44v6 in gastric adenocarcinoma: relationship with lymph node metastasis.
    Joo M; Lee HK; Kang YK
    Anticancer Res; 2003; 23(2B):1581-8. PubMed ID: 12820426
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reduction of syndecan-1 expression in differentiated type early gastric cancer and background mucosa with gastric cellular phenotype.
    Watari J; Saitoh Y; Fujiya M; Shibata N; Tanabe H; Inaba Y; Okamoto K; Maemoto A; Ohta T; Yasuda A; Ayabe T; Ashida T; Yokota K; Obara T; Kohgo Y
    J Gastroenterol; 2004; 39(2):104-12. PubMed ID: 15069616
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Abnormal expression of E-cadherin and beta-catenin may be a molecular marker of submucosal invasion and lymph node metastasis in early gastric cancer.
    Tanaka M; Kitajima Y; Edakuni G; Sato S; Miyazaki K
    Br J Surg; 2002 Feb; 89(2):236-44. PubMed ID: 11856141
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Significance of dysadherin and E-cadherin expression in differentiated-type gastric carcinoma with submucosal invasion.
    Maehata Y; Hirahashi M; Aishima S; Kishimoto J; Hirohashi S; Yao T; Takashima H; Tsuneyoshi M; Oda Y
    Hum Pathol; 2011 Apr; 42(4):558-67. PubMed ID: 21239043
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An immunohistochemical study of E-cadherin expression with correlations to clinicopathological features in gastric cancer.
    Shun CT; Wu MS; Lin JT; Wang HP; Houng RL; Lee WJ; Wang TH; Chuang SM
    Hepatogastroenterology; 1998; 45(22):944-9. PubMed ID: 9755986
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Aberrant E-cadherin expression associated with loss of differentiation and advanced stage in human pancreatic cancer.
    Karayiannakis AJ; Syrigos KN; Chatzigianni E; Papanikolaou S; Alexiou D; Kalahanis N; Rosenberg T; Bastounis E
    Anticancer Res; 1998; 18(6A):4177-80. PubMed ID: 9891464
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Paranuaclear E-cadherin in gastric adenocarcinoma.
    Carpenter PM; Al-Kuran RA; Theuer CP
    Am J Clin Pathol; 2002 Dec; 118(6):887-94. PubMed ID: 12472282
    [TBL] [Abstract][Full Text] [Related]  

  • 12. E-cadherin expression in primary and metastatic gastric cancer: down-regulation correlates with cellular dedifferentiation and glandular disintegration.
    Mayer B; Johnson JP; Leitl F; Jauch KW; Heiss MM; Schildberg FW; Birchmeier W; Funke I
    Cancer Res; 1993 Apr; 53(7):1690-5. PubMed ID: 8453643
    [TBL] [Abstract][Full Text] [Related]  

  • 13. E-cadherin expression as predictive marker of proximal resection line involvement for advanced carcinoma of the gastric cardia.
    Polkowski WP; Skomra DG; Mielko J; Wallner GT; Szumiło J; Zinkiewicz K; Korobowicz EM; van Lanschot JJ
    Eur J Surg Oncol; 2004 Dec; 30(10):1084-92. PubMed ID: 15522555
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Correlation of E-cadherin hypermethylation to tumorigenesis and development of gastric cancer].
    Liu WT; Jiao HL; Yang YL; Wang D; Zhang WM
    Ai Zheng; 2007 Nov; 26(11):1199-203. PubMed ID: 17991318
    [TBL] [Abstract][Full Text] [Related]  

  • 15. E-cadherin expression in early gastric carcinoma and correlation with lymph node metastasis.
    Yi Kim D; Kyoon Joo J; Kyu Park Y; Yeob Ryu S; Soo Kim H; Kyun Noh B; Hwa Lee K; Hyuk Lee J
    J Surg Oncol; 2007 Oct; 96(5):429-35. PubMed ID: 17786966
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of peroxisome proliferator-activated receptor gamma, E-cadherin and matrix metalloproteinases-2 in gastric carcinoma and lymph node metastases.
    He Q; Chen J; Lin HL; Hu PJ; Chen MH
    Chin Med J (Engl); 2007 Sep; 120(17):1498-504. PubMed ID: 17908458
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reduction in membranous expression of beta-catenin and increased cytoplasmic E-cadherin expression predict poor survival in gastric cancer.
    Ramesh S; Nash J; McCulloch PG
    Br J Cancer; 1999 Dec; 81(8):1392-7. PubMed ID: 10604738
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Re-expression of the cadherin-catenin complex in lymph nodes with metastasis in advanced gastric cancer: the relationship with patient survival.
    Liu J; Ikeguchi M; Nakamura S; Kaibara N
    J Exp Clin Cancer Res; 2002 Mar; 21(1):65-71. PubMed ID: 12071532
    [TBL] [Abstract][Full Text] [Related]  

  • 19. E-cadherin expression in prostate cancer: a broad survey using high-density tissue microarray technology.
    Rubin MA; Mucci NR; Figurski J; Fecko A; Pienta KJ; Day ML
    Hum Pathol; 2001 Jul; 32(7):690-7. PubMed ID: 11486167
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of E-cadherin in human ductal breast cancer carcinoma in situ, invasive carcinomas, their lymph node metastases, their distant metastases, carcinomas with recurrence and in recurrence.
    Jeschke U; Mylonas I; Kuhn C; Shabani N; Kunert-Keil C; Schindlbeck C; Gerber B; Friese K
    Anticancer Res; 2007; 27(4A):1969-74. PubMed ID: 17649807
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.